Literature DB >> 19767205

Isolation of a Bacillus strain producing ketone reductase with high substrate tolerance.

Yan Xie1, Jian-He Xu, Yi Xu.   

Abstract

Target reaction-oriented screening from soil samples yielded a ketone reductase-producing Bacillus sp., strain ECU0013, which exhibits excellent stereoselectivity, high substrate tolerance and is capable of regenerating the required cofactor with glucose as a co-substrate. Whole-cells catalyzed the asymmetric reduction of 2-chloro-1-phenylethanone (50mM) to (R)-2-chloro-1-phenylethanol with a 93.3% conversion rate and 99% e.e. (enantiomeric excess). A variety of ketones were enantioselectively reduced by resting cells, giving corresponding chiral alcohols with good to excellent e.e. values. These results suggest the potential of this strain for the industrial production of chiral halogenated aromatic alcohols.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767205     DOI: 10.1016/j.biortech.2009.09.003

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  11 in total

1.  Characterization of a putative stereoselective oxidoreductase from Gluconobacter oxydans and its application in producing ethyl (R)-4-chloro-3-hydroxybutanoate ester.

Authors:  Xu Liu; Rong Chen; Zhongwei Yang; Jiale Wang; Jinping Lin; Dongzhi Wei
Journal:  Mol Biotechnol       Date:  2014-04       Impact factor: 2.695

2.  Towards the discovery of alcohol dehydrogenases: NAD(P)H fluorescence-based screening and characterization of the newly isolated Rhodococcus erythropolis WZ010 in the preparation of chiral aryl secondary alcohols.

Authors:  Chi Yang; Xiangxian Ying; Meilan Yu; Yinjun Zhang; Bin Xiong; Qingqing Song; Zhao Wang
Journal:  J Ind Microbiol Biotechnol       Date:  2012-06-29       Impact factor: 3.346

3.  Engineering the Cad pathway in Escherichia coli to produce glutarate from L-lysine.

Authors:  Jiaping Wang; Cong Gao; Xiulai Chen; Liming Liu
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-27       Impact factor: 4.813

4.  Efficient asymmetric reduction of 4-(trimethylsilyl)-3-butyn-2-one by Candida parapsilosis cells in an ionic liquid-containing system.

Authors:  Bo-Bo Zhang; Wen-Yong Lou; Wen-Jing Chen; Min-Hua Zong
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

5.  Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by Geotrichum candidum CCT 1205 and Rhodotorula glutinis CCT 2182.

Authors:  Lucídio C Fardelone; J Augusto R Rodrigues; Paulo J S Moran
Journal:  Enzyme Res       Date:  2011-06-02

6.  A Comparative Study on Asymmetric Reduction of Ketones Using the Growing and Resting Cells of Marine-Derived Fungi.

Authors:  Hui Liu; Bi-Shuang Chen; Fayene Zeferino Ribeiro de Souza; Lan Liu
Journal:  Mar Drugs       Date:  2018-02-14       Impact factor: 5.118

7.  Immobilized and Free Cells of Geotrichum candidum for Asymmetric Reduction of Ketones: Stability and Recyclability.

Authors:  Hui Liu; Fayene Zeferino Ribeiro de Souza; Lan Liu; Bi-Shuang Chen
Journal:  Molecules       Date:  2018-08-27       Impact factor: 4.411

8.  A novel carbonyl reductase with anti-Prelog stereospecificity from Acetobacter sp. CCTCC M209061: purification and characterization.

Authors:  Xiao-Hong Chen; Ping Wei; Xiao-Ting Wang; Min-Hua Zong; Wen-Yong Lou
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

9.  Highly stereoselective biosynthesis of (R)-α-hydroxy carboxylic acids through rationally re-designed mutation of D-lactate dehydrogenase.

Authors:  Zhaojuan Zheng; Binbin Sheng; Chao Gao; Haiwei Zhang; Tong Qin; Cuiqing Ma; Ping Xu
Journal:  Sci Rep       Date:  2013-12-02       Impact factor: 4.379

10.  Highly enantioselective synthesis of (R)-1,3-butanediol via deracemization of the corresponding racemate by a whole-cell stereoinverting cascade system.

Authors:  Han Zu; Jie Gu; Hui Zhang; Anwen Fan; Yao Nie; Yan Xu
Journal:  Microb Cell Fact       Date:  2020-06-08       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.